Light Mode
$0.3696 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3696, $0.0378 below the day’s high of $0.4074
-0.32 (-46.33%) / 6M
Momentum, market sentiment, and recent alerts
KTTA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -48.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.